ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO)

CUSIP: 00166B105

Q4 2024 13F Holders as of 31 Dec 2024

Security type / class
Equity / Common Stock, par value $0.001 per share
Total 13F shares
41,028,903
Total 13F value
$68,515,761
Holder snapshot 6 visible 7 signals
Share change
-4,604,402
Put/Call ratio
21%
SEC-reported price per share
$1.67
Number of holders
85
Value change
-$8,509,648
Number of buys
47
Open additional details 1 more signal available
Number of sells
45
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
133,751,136

Security key

00166B105

Report period

Q4 2024

Institutions

85

Top holders

10

ALXO full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2025 Previous quarter: Q3 2024 ALX ONCOLOGY HOLDINGS INC SEC filings ALX ONCOLOGY HOLDINGS INC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
TANG CAPITAL PARTNERS LP
Disclosed value leader
venBio Partners LLC
Comparable rows
15/15
Latest evidence
31 Dec 2024
13D/G 13F Lead comparable stake: 6.3% 13D/G row: TANG CAPITAL PARTNERS LP Showing 1-6 of 15 holder rows.

Quick read

TANG CAPITAL PARTNERS LP leads the comparable SEC ownership view at 6.3%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens TANG CAPITAL PARTNERS LP's linked filing trail.
Comparable ownership Top 5
TANG CAPITAL PARTNERS LP 6.3%
FMR LLC 3.4%
venBio Partners LLC 7.3%
TANG CAPITAL MANAGEMENT LLC 3.1%
Vivo Capital, LLC 3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
TANG CAPITAL PARTNERS LP
13D/G
TANG CAPITAL MANAGEMENT, LLC
13D/G
6.3%
$1,681,410
3,296,883 shares
 $0 31 Dec 2024
FMR LLC
13F 13D/G
Company
13F 13D/G
3.4%
from 13D/G
$10,674,493
5,865,106 shares
 — 30 Sep 2024
venBio Partners LLC
13F
Company
13F
7.3%
$17,653,864
9,699,925 shares
 — 30 Sep 2024
TANG CAPITAL MANAGEMENT LLC
13F
Company
13F
3.1%
$7,652,618
4,204,735 shares
 — 30 Sep 2024
Vivo Capital, LLC
13F
Company
13F
3%
$7,342,830
4,034,522 shares
 — 30 Sep 2024
Redmile Group, LLC
13F
Company
13F
2.9%
$6,982,568
3,836,576 shares
 — 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
85
Shares
41,028,903
Rows available
85
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
90
Q4 2024 holders
85
Holder diff
-5
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .